Survey Finds GLP-1 Weight-Loss Medications Influencing Sexuality and Dating among Users

A recent survey conducted by the Kinsey Institute at Indiana University in collaboration with DatingNews.com highlights the significant social and psychological impacts of GLP-1 receptor agonists, commonly used for weight loss, on users' romantic and social lives. The study, which surveyed a nationally representative sample of 2,000 single adults aged 18 to 91 across the United States, reveals that approximately 8% of participants have used GLP-1 drugs such as Ozempic, Wegovy, and ZepBound.

Among these users, over half (59%) reported experiencing notable changes in their dating experiences and intimacy. Many reported actions such as purchasing new clothing to showcase their improved physique (17%), reconnecting with ex-partners (16%), receiving more matches on dating apps (14%), feeling more confident posting photos online (13%), and going on more dates (12%). Dr. Amanda Gesselman from the Kinsey Institute explains that rising GLP-1 use among singles is not only affecting body image but also transforming how individuals approach romantic connections, with some noting reduced appetites and decreased alcohol consumption leading to alternative dating venues.

Furthermore, about half (52%) of GLP-1 users indicated that the medication influenced their sex lives, with some experiencing increased desire (18%) and improved sexual function (16%). Conversely, others reported decreases in libido and sexual satisfaction. Dr. Justin Lehmiller emphasizes that the impact of these drugs on sexuality varies based on factors like dosage, weight loss speed, and lifestyle changes.

Gender differences were prominent, with men more likely to experience both positive and negative effects. Men also reported greater gains in confidence and success in dating contexts, but they also faced higher stigma, with 60% fearing judgment or shame related to GLP-1 use—almost double the rate among women. Concerns about long-term safety, overuse, and perceptions that weight loss should be managed through lifestyle rather than medication were common reasons for reluctance or skepticism toward GLP-1 therapies.

The study underscores the evolving landscape of social interaction influenced by pharmacological weight management, highlighting that such medications may be reshaping intimacy, dating, and societal perceptions in the modern era.

source: https://medicalxpress.com/news/2025-07-survey-glp-weight-loss-drugs.html